Bayer Contemplates Breakup Amidst Poor Performance and Job Cuts
TL;DR Summary
Bayer plans to overhaul its business structure and reduce management layers in response to declining performance, with CEO Bill Anderson stating that zero cash flow despite nearly €50 billion in revenue is unacceptable. While the company's Q3 pharmaceutical sales remained steady at €4.53 billion, its share price has dropped by 20% since last year.
- Bayer unveils big changes to business and headcount to address 'not acceptable' performance Endpoints News
- Bayer weighs break-up options as management job cuts loom Reuters
- Bayer considering breakup but not three-way split, CEO Anderson says (OTCMKTS:BAYRY) Seeking Alpha
- Bayer's CEO Weighs Breakup in U-Turn for German Conglomerate Bloomberg
- Bayer chief blasts conglomerate's performance as 'unacceptable' Financial Times
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
63%
145 → 54 words
Want the full story? Read the original article
Read on Endpoints News